V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20030301 | 20012920 | 1.63 | 65.6 | Adjuvant (A) | 2017-12-29 | 2018-01-26 | FEC + DOCETAXEL | 2 | N | 20106702 | FEC + DOCETAXEL |
| 20030302 | 20109263 | 1.68 | 58.9 | Adjuvant (A) | 2013-11-15 | 2013-11-20 | FEC 100 + DOCETAXEL | 02 | N | 20106704 | FEC + DOCETAXEL |
| 20030303 | 20012921 | null | 71.4 | Adjuvant (A) | null | 2017-03-10 | FEC + DOCETAXEL | null | null | 20106705 | FEC + DOCETAXEL |
| 20030304 | 20012921 | 1.6 | 67.5 | Neo-adjuvant (N) | 2016-07-27 | 2016-07-27 | FEC 100 + DOCETAXEL | N | N | 20106705 | FEC + DOCETAXEL |
| 20030305 | 20012922 | 1.67 | 69.85 | null | 2017-07-04 | 2017-08-03 | FEC + DOCETAXEL | 02 | null | 20106717 | FEC + DOCETAXEL |
| 20030306 | 20012922 | 1.68 | 122.2 | Adjuvant (A) | 2013-11-20 | 2013-11-20 | FEC + DOCETAXEL | 2 | N | 20106717 | FEC + DOCETAXEL |
| 20030307 | 20012923 | 1.62 | 102.9 | Adjuvant (A) | 2016-09-28 | 2016-10-17 | FEC + DOCETAXEL | 02 | N | 20106722 | FEC + DOCETAXEL |
| 20030308 | 20012923 | 1.57 | 57 | Neo-adjuvant (N) | 2015-10-13 | 2015-10-13 | FEC 100 + DOCETAXEL | 2 | N | 20106722 | FEC + DOCETAXEL |
| 20030309 | 20012924 | 1.62 | 66 | Neo-adjuvant (N) | 2013-07-04 | 2013-07-05 | FEC 100 + DOCETAXEL | 02 | N | 20106735 | FEC + DOCETAXEL |
| 20030310 | 20012924 | null | null | Neo-adjuvant (N) | 2016-07-14 | 2016-07-29 | FEC + DOCETAXEL | 99 | null | 20106735 | FEC + DOCETAXEL |
| 20030311 | 20012925 | 1.63 | 62.25 | Adjuvant (A) | 2016-01-30 | 2016-02-24 | FEC + DOCETAXEL | 2 | null | 20106740 | FEC + DOCETAXEL |
| 20030312 | 20012925 | 1.65 | 64.8 | Adjuvant (A) | 2013-10-05 | 2013-10-06 | FEC + DOCETAXEL | 02 | null | 20106740 | FEC + DOCETAXEL |
| 20030313 | 20012926 | 1.68 | 54.8 | Adjuvant (A) | 2015-10-05 | 2015-10-18 | FEC + DOCETAXEL | N | N | 20106747 | FEC + DOCETAXEL |
| 20030314 | 20012926 | 1.57 | 62.6 | Adjuvant (A) | 2016-11-19 | 2016-11-19 | FEC + DOCETAXEL | N | N | 20106747 | FEC + DOCETAXEL |
| 20030315 | 20012927 | 1.69 | 65.6 | Adjuvant (A) | 2013-11-16 | 2013-12-01 | FEC + DOCETAXEL | 2 | N | 20106754 | FEC + DOCETAXEL |
| 20030316 | 20012927 | 1.69 | 69 | null | 2015-03-23 | 2015-04-12 | FEC + DOCETAXEL | 99 | N | 20106754 | FEC + DOCETAXEL |
| 20030317 | 20012927 | 1.58 | 73 | Adjuvant (A) | 2017-05-27 | 2017-06-07 | FEC 100 + DOCETAXEL | N | N | 20106754 | FEC + DOCETAXEL |
| 20030318 | 20012927 | 1.7 | 103 | Neo-adjuvant (N) | 2017-06-15 | 2017-07-11 | FEC + DOCETAXEL | N | N | 20106754 | FEC + DOCETAXEL |
| 20030319 | 20012928 | 1.67 | 63.5 | null | 2013-03-14 | 2013-03-21 | FEC + DOCETAXEL | N | N | 20106765 | FEC + DOCETAXEL |
| 20030320 | 20012929 | 1.57 | 61 | Adjuvant (A) | 2017-05-22 | 2017-06-12 | FEC + DOCETAXEL | N | N | 20106767 | FEC + DOCETAXEL |
| 20030321 | 20012930 | 1.57 | 47.6 | Adjuvant (A) | 2017-07-01 | 2017-07-21 | FEC + DOCETAXEL | 02 | N | 20106773 | FEC + DOCETAXEL |
| 20030322 | 20012931 | 1.57 | null | Neo-adjuvant (N) | 2015-11-03 | 2015-11-03 | FEC 100 + DOCETAXEL | 2 | N | 20106775 | FEC + DOCETAXEL |
| 20030323 | 20012931 | null | 70 | Disease modification (D) | 2013-02-19 | 2013-02-24 | FEC + DOCETAXEL | 02 | N | 20106775 | FEC + DOCETAXEL |
| 20030324 | 20012932 | 1.74 | null | Adjuvant (A) | 2014-01-15 | 2014-02-05 | FEC + DOCETAXEL | N | N | 20106781 | FEC + DOCETAXEL |
| 20030325 | 20012933 | 1.58 | null | Adjuvant (A) | 2017-05-21 | 2017-06-05 | FEC + DOCETAXEL | N | N | 20106790 | FEC + DOCETAXEL |
| 20030326 | 20012933 | null | null | Adjuvant (A) | 2017-02-27 | 2017-03-24 | FEC + DOCETAXEL | 2 | null | 20106790 | FEC + DOCETAXEL |
| 20030327 | 20012933 | null | 114 | Disease modification (D) | 2015-10-23 | 2015-10-30 | FEC + DOCETAXEL | N | N | 20106790 | FEC + DOCETAXEL |
| 20030328 | 20012933 | 1.6 | 94 | Adjuvant (A) | 2015-12-08 | 2015-12-08 | FEC 100 + DOCETAXEL | 02 | N | 20106790 | FEC + DOCETAXEL |
| 20030329 | 20012933 | 1.56 | 81.4 | Neo-adjuvant (N) | null | 2016-07-23 | FEC + DOCETAXEL | null | null | 20106790 | FEC + DOCETAXEL |
| 20030330 | 20012934 | null | null | Neo-adjuvant (N) | null | 2017-07-20 | FEC + DOCETAXEL | 99 | null | 20106807 | FEC + DOCETAXEL |
| 20030331 | 20012934 | 1.73 | 87 | Neo-adjuvant (N) | 2017-11-10 | 2017-11-24 | FEC + DOCETAXEL | N | N | 20106807 | FEC + DOCETAXEL |
| 20030332 | 20012934 | 1.6 | 70.8 | Not known (9) | 2015-07-12 | 2015-09-14 | FEC 100 + DOCETAXEL | 2 | N | 20106807 | FEC + DOCETAXEL |
| 20030333 | 20012935 | 1.71 | 122 | Not known (9) | 2016-08-29 | 2016-08-31 | FEC + DOCETAXEL | 2 | N | 20106832 | FEC + DOCETAXEL |
| 20030334 | 20012935 | 1.7 | 66.6 | Disease modification (D) | 2016-07-29 | 2016-07-29 | FEC 100 + DOCETAXEL | 02 | N | 20106832 | FEC + DOCETAXEL |
| 20030335 | 20012936 | 1.79 | 65 | Adjuvant (A) | 2016-08-29 | 2016-09-06 | FEC + DOCETAXEL | 02 | null | 20106835 | FEC + DOCETAXEL |
| 20030336 | 20012937 | 1.53 | null | Neo-adjuvant (N) | 2016-07-21 | 2016-07-31 | FEC + DOCETAXEL | N | N | 20106836 | FEC + DOCETAXEL |
| 20030337 | 20012937 | null | null | Neo-adjuvant (N) | 2016-03-21 | 2016-04-06 | FEC + DOCETAXEL | N | N | 20106836 | FEC + DOCETAXEL |
| 20030338 | 20012938 | null | null | Adjuvant (A) | null | 2015-07-13 | FEC 100 + DOCETAXEL | null | N | 20106842 | FEC + DOCETAXEL |
| 20030339 | 20012938 | null | null | Adjuvant (A) | 2015-09-15 | 2015-09-16 | FEC + DOCETAXEL | N | null | 20106842 | FEC + DOCETAXEL |
| 20030340 | 20012938 | 1.58 | 90 | Adjuvant (A) | 2016-09-21 | 2016-09-21 | FEC + DOCETAXEL | 02 | N | 20106842 | FEC + DOCETAXEL |
| 20030341 | 20012939 | 0.76 | 54.7 | Adjuvant (A) | 2013-09-30 | 2013-09-30 | FEC + DOCETAXEL | 2 | N | 20106858 | FEC + DOCETAXEL |
| 20030342 | 20012939 | 1.58 | 58.8 | Adjuvant (A) | 2016-12-08 | 2016-12-08 | FEC + DOCETAXEL | 2 | N | 20106858 | FEC + DOCETAXEL |
| 20030343 | 20012939 | null | null | null | 2014-02-14 | 2014-02-27 | FEC 100 + DOCETAXEL | N | N | 20106858 | FEC + DOCETAXEL |
| 20030344 | 20012939 | null | null | Adjuvant (A) | 2013-10-15 | 2013-10-28 | FEC + DOCETAXEL | 99 | null | 20106858 | FEC + DOCETAXEL |
| 20030345 | 20012940 | null | null | null | 2015-03-10 | 2015-03-23 | FEC + DOCETAXEL | N | N | 20106873 | FEC + DOCETAXEL |
| 20030346 | 20012941 | null | 87.3 | Adjuvant (A) | 2015-09-17 | 2015-09-22 | FEC + DOCETAXEL | N | N | 20106875 | FEC + DOCETAXEL |
| 20030347 | 20012941 | 1.63 | null | Palliative (P) | 2013-08-25 | 2013-09-09 | FEC + DOCETAXEL | 2 | N | 20106875 | FEC + DOCETAXEL |
| 20030348 | 20012941 | 1.63 | 59.4 | Not known (9) | 2013-03-19 | 2013-03-25 | FEC + DOCETAXEL | 02 | null | 20106875 | FEC + DOCETAXEL |
| 20030349 | 20012942 | 1.68 | 66.2 | Adjuvant (A) | 2013-05-08 | 2013-05-09 | FEC 100 + DOCETAXEL | 2 | N | 20106881 | FEC + DOCETAXEL |
| 20030350 | 20012942 | 1.51 | 60 | Curative (C) | 2013-08-22 | 2013-08-22 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20106881 | FEC + DOCETAXEL |